Allosteric targeting of receptor tyrosine kinases

Hélène Vanacker, Valéry Attignon, Mehdi Brahmi, Armelle Dufresne, Philippe A. Cassier, Mélodie Carbonnaux, Daniel Pissaloux, Sandrine Boyault, Q.L. Wang, Olivier Trédan, Franck Tirode, Jean Yves Blay

Article2018

Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Preprint2023

Data from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Preprint2023